Status:

WITHDRAWN

Neurobiology of Opioid Dependence: 5 - 5

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Opioid-Related Disorders

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.

Eligibility Criteria

Please contact site for information.

Key Trial Info

Start Date :

January 1 1993

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 1998

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00000196

Start Date

January 1 1993

End Date

January 1 1998

Last Update

June 3 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Connecticut Healthcare System

New Haven, Connecticut, United States, 06519

Neurobiology of Opioid Dependence: 5 - 5 | DecenTrialz